SEQUENT.NS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 12:00):

Stats
Tagesvolumen	667 542
Durchschnittsvolumen	1.59M
Marktkapitalisierung	31.15B
EPS	INR0 ( 2024-02-13 )
Nächstes Ertragsdatum	( INR0 ) 2024-05-20
Last Dividend	INR0.500 ( 2021-09-08 )
Next Dividend	INR0 ( N/A )
P/E	-24.07
ATR14	INR0.170 (0.14%)

Volumen Korrelation

Lang: 0.54 (weak)

Kurz: -0.83 (strong negative)

Signal:(41.021) Neutral

Sequent Scientific Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Sequent Scientific Korrelation - Währung/Rohstoff

-0.13
( neutral )

-0.39
( neutral )

0.00
( neutral )

-0.09
( neutral )

-0.12
( neutral )

-0.32
( neutral )

Sequent Scientific Finanzdaten

Annual	2022
Umsatz:	INR14.21B
Bruttogewinn:	INR5.87B (41.32 %)
EPS:	INR-4.88

FY	2022
Umsatz:	INR14.21B
Bruttogewinn:	INR5.87B (41.32 %)
EPS:	INR-4.88

FY	2022
Umsatz:	INR14.10B
Bruttogewinn:	INR5.66B (40.12 %)
EPS:	INR1.670

FY	2021
Umsatz:	INR13.62B
Bruttogewinn:	INR6.25B (45.91 %)
EPS:	INR3.87

Financial Reports:

No articles found.

Sequent Scientific Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Sequent Scientific Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 1.087 - No dividend growth expected in the near future

Information

First Dividend	INR0.200	2017-11-20
Last Dividend	INR0.500	2021-09-08
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	INR0.900	--
Avg. Dividend % Per Year	0.04%	--
Score	0.38	--
Div. Sustainability Score	0
Div.Growth Potential Score	1.087
Div. Directional Score	0.450	--

Next Divdend (Est)
(2025-03-10)

INR0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

0.38

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0.200	0.30%
2020	INR0	0.00%
2021	INR0.500	0.29%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SMSPHARMA.NS	Ex Dividend Junior	2023-09-22	Annually	18	0.12%
MINDTECK.NS	Dividend Junior	2023-08-04	Sporadic	8	0.28%
HBSL.NS	Dividend Junior	2023-08-11	Sporadic	12	0.78%
BEPL.NS	Dividend King	2023-07-25	Semi-Annually	20	4.91%
RADICO.NS	Dividend Junior	2023-09-14	Annually	22	0.24%
KHAICHEM.NS	No Dividend Player	2023-07-21	Annually	5	0.32%
EMAMIPAP.NS	Dividend Junior	2023-09-05	Annually	3	0.56%
AJANTPHARM.NS	Dividend Junior	2023-08-04	Annually	23	0.57%
SUNTV.NS	Dividend Knight	2023-08-22	Quarterly	19	1.94%
NAVNETEDUL.NS	Dividend Junior	2023-08-07	Annually	22	1.10%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0935	1.500	-1.869	-2.80	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	-0.186	1.500	-3.18	-4.77	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	-1.024	1.000	-1.490	-1.490	[3 - 30]
operatingCashFlowPerShareTTM	3.93	2.00	8.69	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.93	2.00	8.03	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.374	1.000	7.09	7.09	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0346	1.000	-2.69	-2.69	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.187

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-24.14	1.000	-2.54	0	[1 - 100]
returnOnEquityTTM	-0.186	2.50	-2.04	-4.77	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.93	2.00	8.69	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.93	2.00	8.69	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.425	1.500	-0.502	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0711	1.000	-0.723	0	[0.1 - 0.5]
Total Score				1.087

Sequent Scientific

Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.